Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21736 | 350 | 32.7 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2844 | 2448 | PEPTIDE DEFORMYLASE//ENOYL ACP REDUCTASE//PLATENSIMYCIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PEPTIDE DEFORMYLASE | Author keyword | 97 | 78% | 18% | 64 |
2 | PEPTIDE DEFORMYLASE INHIBITOR | Author keyword | 12 | 86% | 2% | 6 |
3 | DEFORMYLASE | Author keyword | 10 | 73% | 2% | 8 |
4 | PEPTIDE DEFORMYLASE PDF | Author keyword | 9 | 83% | 1% | 5 |
5 | PEPTIDE DEFORMYLASE INHIBITORS | Author keyword | 8 | 75% | 2% | 6 |
6 | ACTINONIN | Author keyword | 8 | 44% | 4% | 14 |
7 | INFECT DIS THER EUT AREA | Address | 6 | 80% | 1% | 4 |
8 | HUMAN PEPTIDE DEFORMYLASE | Author keyword | 6 | 100% | 1% | 4 |
9 | PROMEDITECH LTD | Address | 6 | 100% | 1% | 4 |
10 | PDF INHIBITOR | Author keyword | 4 | 75% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PEPTIDE DEFORMYLASE | 97 | 78% | 18% | 64 | Search PEPTIDE+DEFORMYLASE | Search PEPTIDE+DEFORMYLASE |
2 | PEPTIDE DEFORMYLASE INHIBITOR | 12 | 86% | 2% | 6 | Search PEPTIDE+DEFORMYLASE+INHIBITOR | Search PEPTIDE+DEFORMYLASE+INHIBITOR |
3 | DEFORMYLASE | 10 | 73% | 2% | 8 | Search DEFORMYLASE | Search DEFORMYLASE |
4 | PEPTIDE DEFORMYLASE PDF | 9 | 83% | 1% | 5 | Search PEPTIDE+DEFORMYLASE+PDF | Search PEPTIDE+DEFORMYLASE+PDF |
5 | PEPTIDE DEFORMYLASE INHIBITORS | 8 | 75% | 2% | 6 | Search PEPTIDE+DEFORMYLASE+INHIBITORS | Search PEPTIDE+DEFORMYLASE+INHIBITORS |
6 | ACTINONIN | 8 | 44% | 4% | 14 | Search ACTINONIN | Search ACTINONIN |
7 | HUMAN PEPTIDE DEFORMYLASE | 6 | 100% | 1% | 4 | Search HUMAN+PEPTIDE+DEFORMYLASE | Search HUMAN+PEPTIDE+DEFORMYLASE |
8 | PDF INHIBITOR | 4 | 75% | 1% | 3 | Search PDF+INHIBITOR | Search PDF+INHIBITOR |
9 | FUMIMYCIN | 3 | 100% | 1% | 3 | Search FUMIMYCIN | Search FUMIMYCIN |
10 | ANTIBACTERIAL DRUG DESIGN | 2 | 67% | 1% | 2 | Search ANTIBACTERIAL+DRUG+DESIGN | Search ANTIBACTERIAL+DRUG+DESIGN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POLYPEPTIDE DEFORMYLASE | 135 | 97% | 11% | 37 |
2 | ACTINONIN | 61 | 77% | 12% | 41 |
3 | METHIONYL TRNAFMET FORMYLTRANSFERASE | 44 | 85% | 7% | 23 |
4 | BB 3497 | 41 | 90% | 5% | 18 |
5 | NVP PDF 713 | 33 | 100% | 4% | 13 |
6 | BACTERIUM LEPTOSPIRA INTERROGANS | 23 | 86% | 3% | 12 |
7 | TERMINAL METHIONINE EXCISION | 23 | 65% | 6% | 22 |
8 | LBM415 | 14 | 100% | 2% | 7 |
9 | FORMYLTRANSFERASE | 11 | 37% | 7% | 23 |
10 | LBM415 NVP PDF 713 | 9 | 83% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Bacterial peptide deformylase inhibitors: A new class of antibacterial agents | 2005 | 71 | 68 | 96% |
Deformylase as a novel antibacterial target | 2001 | 80 | 41 | 85% |
Peptide deformylase - a promising therapeutic target for tuberculosis and antibacterial drug discovery | 2009 | 16 | 94 | 70% |
Therapeutic potential of peptide deformylase inhibitors | 2005 | 23 | 48 | 92% |
Novel approaches to antimicrobial therapy: Peptide deformylase | 2002 | 40 | 25 | 84% |
Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents | 2000 | 117 | 54 | 61% |
Cotranslational processing mechanisms: towards a dynamic 3D model | 2009 | 16 | 69 | 28% |
DOES PATENT STRATEGY SHAPE THE LONG-RUN SUPPLY OF PUBLIC KNOWLEDGE? EVIDENCE FROM HUMAN GENETICS | 2009 | 27 | 69 | 14% |
Peptide deformylase inhibitors: a survey of the patent literature | 2005 | 0 | 71 | 66% |
The future of natural products as a source of new antibiotics | 2007 | 19 | 13 | 15% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INFECT DIS THER EUT AREA | 6 | 80% | 1.1% | 4 |
2 | PROMEDITECH LTD | 6 | 100% | 1.1% | 4 |
3 | CRISTALLOG RMN BIOL PHARM | 2 | 67% | 0.6% | 2 |
4 | UPR40 | 2 | 40% | 1.1% | 4 |
5 | ANTIBACTERIAL DISCOVERY PERFORMANCE UNIT | 2 | 31% | 1.4% | 5 |
6 | PRBMH | 1 | 100% | 0.6% | 2 |
7 | UPR2355 | 1 | 11% | 2.6% | 9 |
8 | CHIM SYNTH ORGAN | 1 | 50% | 0.3% | 1 |
9 | ENVIRONM MICROBIAL | 1 | 50% | 0.3% | 1 |
10 | NEUROSCI NEUROBIOTECHNOL | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000173516 | MACROLACTIN A//7 O SUCCINYL MACROLACTIN A//MACROLACTINS |
2 | 0.0000143706 | TNP 470//METHIONINE AMINOPEPTIDASE//AGM 1470 |
3 | 0.0000101606 | ESSENTIAL GENES//SUBTRACTIVE GENOMICS//ESSENTIAL GENE |
4 | 0.0000071938 | N TERMINAL ACETYLTRANSFERASE//ARD1//LIFE SCI 4 401 |
5 | 0.0000065036 | CEFTAROLINE//CEFTOBIPROLE//CEFTOLOZANE TAZOBACTAM |
6 | 0.0000058675 | PLEUROMUTILIN//PLEUROMUTILIN DERIVATIVES//VALNEMULIN |
7 | 0.0000042941 | TACE INHIBITORS//TACE INHIBITOR//MMP INHIBITORS |
8 | 0.0000042175 | DEOXYBENZOINS//BIOMOLEC FUNCT//DEOXYBENZOIN DERIVATIVES |
9 | 0.0000031561 | LPXC//LPXC INHIBITORS//LPXA |
10 | 0.0000030185 | LINEZOLID//OXAZOLIDINONE//LINEZOLID RESISTANCE |